Peter W. Jeffs

2.5k total citations
104 papers, 1.9k citations indexed

About

Peter W. Jeffs is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Peter W. Jeffs has authored 104 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Organic Chemistry, 30 papers in Molecular Biology and 18 papers in Pharmacology. Recurrent topics in Peter W. Jeffs's work include Chemical synthesis and alkaloids (38 papers), Advanced Synthetic Organic Chemistry (14 papers) and Plant and fungal interactions (13 papers). Peter W. Jeffs is often cited by papers focused on Chemical synthesis and alkaloids (38 papers), Advanced Synthetic Organic Chemistry (14 papers) and Plant and fungal interactions (13 papers). Peter W. Jeffs collaborates with scholars based in United States, Germany and United Kingdom. Peter W. Jeffs's co-authors include D. G. Graham, Sarah L. Heald, Ernest Wenkert, Luciano Mueller, Robert J. Lefkowitz, T N Lavin, David Farrier, Michael Ashburner, Marc G. Caron and Stephen C. Brown and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Peter W. Jeffs

104 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter W. Jeffs United States 26 852 722 373 242 181 104 1.9k
Raymond Cooper United States 23 1.1k 1.2× 500 0.7× 452 1.2× 115 0.5× 399 2.2× 64 2.0k
A. BROSSI United States 23 639 0.8× 954 1.3× 297 0.8× 265 1.1× 277 1.5× 139 2.0k
John M. Cassady United States 31 2.0k 2.4× 953 1.3× 443 1.2× 280 1.2× 46 0.3× 136 4.0k
Cornelis Erkelens Netherlands 28 1.4k 1.7× 309 0.4× 287 0.8× 149 0.6× 105 0.6× 61 2.5k
Yves Chapleur France 27 1.3k 1.6× 1.9k 2.7× 316 0.8× 272 1.1× 102 0.6× 154 2.6k
Vicente J. Arán Spain 29 799 0.9× 1.5k 2.1× 279 0.7× 77 0.3× 71 0.4× 121 2.7k
Farouk S. El‐Feraly Saudi Arabia 30 1.6k 1.9× 597 0.8× 374 1.0× 362 1.5× 69 0.4× 152 3.3k
Marcel Delaforge France 27 659 0.8× 214 0.3× 200 0.5× 535 2.2× 60 0.3× 71 1.8k
Masato Koreeda United States 34 1.7k 2.0× 1.9k 2.6× 248 0.7× 400 1.7× 405 2.2× 136 3.9k
Edward Leete United States 30 1.7k 2.0× 1.0k 1.4× 423 1.1× 268 1.1× 37 0.2× 181 3.1k

Countries citing papers authored by Peter W. Jeffs

Since Specialization
Citations

This map shows the geographic impact of Peter W. Jeffs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter W. Jeffs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter W. Jeffs more than expected).

Fields of papers citing papers by Peter W. Jeffs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter W. Jeffs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter W. Jeffs. The network helps show where Peter W. Jeffs may publish in the future.

Co-authorship network of co-authors of Peter W. Jeffs

This figure shows the co-authorship network connecting the top 25 collaborators of Peter W. Jeffs. A scholar is included among the top collaborators of Peter W. Jeffs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter W. Jeffs. Peter W. Jeffs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hamaguchi, Nobuko, et al.. (1998). α1-Adrenergic Receptor Subtype Determinants for 4-Piperidyl Oxazole Antagonists. Biochemistry. 37(16). 5730–5737. 16 indexed citations
2.
Brown, Frank K., et al.. (1992). Solution conformation of human big endothelin-1. Journal of Biomolecular NMR. 2(5). 407–420. 7 indexed citations
3.
Brown, Frank K., Judith C. Hempel, & Peter W. Jeffs. (1992). NMR restraint analysis of transforming growth factor α: A key component for NMR structure refinement. Proteins Structure Function and Bioinformatics. 13(4). 306–326. 2 indexed citations
5.
Jeffs, Peter W. & Michael Ashburner. (1991). Processed pseudogenes inDrosophila. Proceedings of the Royal Society B Biological Sciences. 244(1310). 151–159. 49 indexed citations
6.
Brown, Frank K., et al.. (1990). Solution structures of human transforming growth factor .alpha. derived from 1H NMR data. Biochemistry. 29(34). 7805–7813. 52 indexed citations
7.
Brown, Stephen C., Luciano Mueller, & Peter W. Jeffs. (1989). Proton-NMR assignment and secondary structural elements of human transforming growth factor. Biochemistry. 28(2). 593–599. 22 indexed citations
8.
Dickinson, Kenneth E.J., Sarah L. Heald, Peter W. Jeffs, R.J. Lefkowitz, & Marc G. Caron. (1985). Covalent labeling of the beta-adrenergic ligand-binding site with para-(bromoacetamidyl)benzylcarazolol. A highly potent beta-adrenergic affinity label.. Molecular Pharmacology. 27(5). 499–506. 19 indexed citations
9.
Jeffs, Peter W., George W. Chan, Robert D. Sitrin, N. L. HOLDER, & Charles DeBrosse. (1985). The structure of the glycolipid components of the aridicin antibiotic complex. The Journal of Organic Chemistry. 50(10). 1726–1731. 17 indexed citations
10.
Lavin, T N, P Nambi, Sarah L. Heald, et al.. (1982). 125I-labeled p-azidobenzylcarazolol, a photoaffinity label for the beta-adrenergic receptor. Characterization of the ligand and photoaffinity labeling of beta 1- and beta 2-adrenergic receptors.. Journal of Biological Chemistry. 257(20). 12332–12340. 63 indexed citations
11.
Jeffs, Peter W., et al.. (1982). Sceletium alkaloids. Part 12. Synthesis of (.+-.)-mesembranol and (.+-.)-O-methyljoubertiamine. Aza-ring expansion of cis-bicyclo[4.2.0]octanones. The Journal of Organic Chemistry. 47(20). 3881–3886. 11 indexed citations
12.
Lavin, T N, Sarah L. Heald, Peter W. Jeffs, et al.. (1981). Photoaffinity labeling of the beta-adrenergic receptor.. Journal of Biological Chemistry. 256(22). 11944–11950. 46 indexed citations
13.
Jeffs, Peter W., et al.. (1975). 13.beta.-Hydroxystylopine. Structure and synthesis. The Journal of Organic Chemistry. 40(5). 644–647. 8 indexed citations
14.
Lynn, William S., et al.. (1974). CHEMOTAXIS AND COTTON EXTRACTS. Annals of the New York Academy of Sciences. 221(1). 163–173. 18 indexed citations
15.
Döpke, Werner, et al.. (1968). The structures of amurine and nudaurine. Tetrahedron. 24(12). 4459–4476. 10 indexed citations
16.
Döpke, Werner & Peter W. Jeffs. (1968). Zur struktur und stereochemie des isotazettins. Tetrahedron Letters. 9(11). 1307–1310. 1 indexed citations
17.
Jeffs, Peter W., et al.. (1967). Biosynthesis of mesembrine. Incorporation of one-carbon units and the origin of the C6 unit. Journal of the American Chemical Society. 89(10). 2509–2510. 3 indexed citations
18.
Döpke, Werner, et al.. (1966). [Amuronin and amuroline, 2 new dihydroproaporphine alkaloids].. PubMed. 21(6). 379–80. 1 indexed citations
19.
Jeffs, Peter W.. (1965). Stereochemistry of corydaline and related alkaloids. Cellular and Molecular Life Sciences. 21(12). 690–692. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026